US HUPO 2026

Discovery to targeted assays for fingerprinting flow-sorted immune from healthy human donors

Ariana E. Shannon1, Robert Davenport2, Yoshi Koguichi2, Zihai Li2, Mark Rubinstein2, Amanda Berg3, Gary Valaskovic3, Helena Svobodova3, Brian C. Searle1

1Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; 2Pelotonia Institute for Immuno-Oncology, Ohio State University, Columbus, OH; 3New Objective, Inc., Littleton, MA

Download PDF →

ASMS 2025

A Novel Nanoflow LC-MS Platform for the Robust Identification of HLA Peptides from High Value Clinical Samples

Helena Svobodova1, Gary Valaskovic1, Amanda Berg1, Reese Hitchings2, David Lewis2, Nicholas Cheung2, Robert Salzler2

1New Objective, Inc, Littleton, MA; 2Regeneron, Tarrytown, NY

Download PDF →

Soluble APPβ and sAPPα Kinetic Curve Results are improved with utilization of a novel nanoflow LC-MS Platform

Justyna Dobrowolska Zakaria1; Helena Svobodova2; Gary Valaskovic2; Amanda Berg2; Robert J. Vassar1

1Northwestern University Feinberg School of Medicine, Chicago, IL; 2New Objective Inc, Littleton, MA

Download PDF →

HUPO 2025

A Novel Nanoflow LC-MS Platform for the Robust Identification of HLA Peptides from High Value Clinical Samples

Helena Svobodova1, Gary Valaskovic1, Amanda Berg1, Reese Hitchings2, David Lewis2, Nicholas Cheung2, Robert Salzler2

1New Objective, Inc, Littleton, MA; 2Regeneron, Tarrytown, NY

Download PDF →